Related Experiment Videos
Current expectations in dynamic cardiomyoplasty
L F Moreira1, E A Bocchi, N A Stolf
1Instituto do Coração, Faculdade de Medicina, Universidade de São Paulo, Brazil.
Insights
Dynamic cardiomyoplasty improved heart function in severe cardiomyopathy patients. Survival rates were promising, though outcomes depend on patient condition and muscle flap health.
Area of Science:
- Cardiology
- Cardiac Surgery
- Regenerative Medicine
Background:
- Severe cardiomyopathies, including dilated and ischemic types, significantly impair cardiac function.
- Patients with New York Heart Association (NYHA) class III or IV heart failure have limited treatment options.
- Dynamic cardiomyoplasty is an investigational surgical procedure for advanced heart failure.
Purpose of the Study:
- To evaluate the efficacy and outcomes of dynamic cardiomyoplasty in patients with severe dilated or ischemic cardiomyopathy.
- To assess the impact of dynamic cardiomyoplasty on cardiac function, survival rates, and clinical status.
Main Methods:
- A cohort of 21 patients with NYHA class III or IV cardiomyopathy underwent dynamic cardiomyoplasty.
- Postoperative follow-up included clinical assessment, radioisotopic angiography, and heart catheterization.
- Actuarial survival analysis was performed over a mean follow-up period of 17.6 months.
Main Results:
- No operative mortality was observed.
- Actuarial survival rates were 73.2% at 1 year and 65.9% at 2 years.
- Surviving patients demonstrated improved functional class and significant enhancement in left ventricular function, including increased ejection fraction and improved regional wall motion.
Conclusions:
- Dynamic cardiomyoplasty can lead to significant functional and hemodynamic improvements in select patients with severe cardiomyopathy.
- Factors such as muscle flap ischemic compromise and preoperative patient condition appear to influence the success and long-term outcome of the procedure.
- Further research is warranted to optimize patient selection and surgical technique for dynamic cardiomyoplasty.
Abstract:
Dynamic cardiomyoplasty has been evaluated in the treatment of severe cardiomyopathies. This report outlines the results of this procedure in 21 patients with dilated or ischemic cardiomyopathy who were in New York Heart Association class III or IV before operation. There were no operative deaths. Patients were followed up for a mean of 17.6 months. Eight patients died during late follow-up, and actuarial survival rates were 73.2% at 1 year and 65.9% at 2 years of follow-up. Functional class improvement was documented in the surviving patients. Furthermore, significant improvement in left ventricular function was demonstrated by radioisotopic angiography and by heart catheterization for more than 2 years after the operation. These studies documented that left ventricular ejection fraction increased as a result of global improvement in regional wall motion. Absence of clinical and hemodynamic improvement after cardiomyoplasty seems to be related to muscle flap ischemic compromise, whereas the patient's condition before operation seems to influence the long-term outcome of cardiomyoplasty.